John Overdeck’s ClearPoint Neuro CLPT Stock Holding History

John Overdeck’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Sell	154,851 -55,929	-27%	-$699K	﹤0.01%	2698
2026 Q1	$1.92M	Sell	210,780 -8,441	-4%	-$107K	﹤0.01%	2785
2025 Q4	$3M	Sell	219,221 -91,305	-29%	-$1.69M	﹤0.01%	2145
2025 Q3	$6.77M	Buy	310,526 +288,598	+1,316%	+$3.4M	0.01%	1223
2025 Q2	$262K	Buy	+21,928	New	+$276K	﹤0.01%	2836
2025 Q1	–	Sell	-10,314	Closed	-$159K	–	3243
2024 Q4	$159K	Buy	+10,314	New	+$134K	﹤0.01%	2907
2022 Q1	–	Sell	-133,666	Closed	-$1.5M	–	2935
2021 Q4	$1.5M	Buy	+133,666	New	+$2M	﹤0.01%	2193

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

John Overdeck's CLPT Position: Q2 2026 in Review

John Overdeck reduced its ClearPoint Neuro (CLPT) stake by 27% in Q2 2026, selling an estimated $699K and leaving 154,851 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

John Overdeck first reported a position in CLPT in Q4 2021 and has held it in 7 quarters since. The position peaked at $6.77M in Q3 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

John Overdeck held 154,851 shares of ClearPoint Neuro worth $2.76M as of Q2 2026.
John Overdeck sold 55,929 ClearPoint Neuro shares in Q2 2026, an estimated $699K.
ClearPoint Neuro made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2698 holding.
John Overdeck first reported a position in ClearPoint Neuro in Q4 2021 and has held it in 7 quarters since.
John Overdeck's ClearPoint Neuro position peaked at $6.77M in Q3 2025.
128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.